Pharmafile Logo

News and Press Releases

Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials

This investment will improve the healthcare experience for patients, reinforcing Dassault Systèmes’ role in the industry’s transformation Click Therapeutics will gain access to Dassault Systèmes’ global presence and expertise to...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: March 19, 2025

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

Medable Achieves Landmark CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union

4 March 2025 -- California, US -- Medable Inc., a leading provider of clinical development technology, announced that its eConsent and eCOA solutions have been approved for use in two...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2025

Medable
media@medable.com
525 University Ave Suite A70 Palo Alto, CA 94301

Lundbeck announces positive results from 12-month Open-Label Extension (OLE) of the PACIFIC trial evaluating bexicaserin in participants with Developmental and Epileptic Encephalopathies

Bexicaserin achieved an overall median seizure reduction of 59.3 percent in countable motor seizures over a 12-month open-label extension (OLE) treatment period. The treatment with bexicaserin demonstrated favorable safety and...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 30, 2025

Lundbeck
Iveco House Station Road Watford Hertfordshire WD17 1ET

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

OKN4395 is the first Owkin development program to leverage K1.0, Owkin’s AI-powered Operating System, from asset selection to clinical development optimization This asset is a highly selective triple inhibitor of...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 30, 2025

Owkin
https://www.owkin.com/
14/16 Bd Poissonnière, 75009 Paris

Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption

Growing industry confidence drives shift in digital strategy for clinical trial sponsors 28 January 2025 -- California, US -- Medable Inc., a leading provider of clinical development technology, today announced 80%...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 28, 2025

Medable
media@medable.com
525 University Ave Suite A70 Palo Alto, CA 94301

Clinigen Announces Strategic Partnership with Tepsivo

Expanding Client Choice with AI-Powered Pharmacovigilance Solutions 27 January 2025 -- London, UK -- Clinigen, the global specialist pharmaceutical services company, today announced a strategic partnership with Tepsivo, a pioneering...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 27, 2025

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Medidata and Tigermed Renew Strategic Partnership Aimed at Accelerating Clinical Trials Globally

Extended partnership will enhance study efficiency and regulatory compliance, leveraging Medidata’s platform to improve access to new therapies 23 January 2025 -- New York, US -- Medidata, a Dassault Systèmes brand...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 23, 2025

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placebo Navacaprant showed an efficacy signal in...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 2, 2025

Neumora
investors@neumoratx.com
490 Arsenal Way, Suite 200 Watertown, MA 02472

Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring

Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use...

Category: Biotechnology, Other, Pharmaceutical
Posted: December 17, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

Science-driven collaboration ameliorates neurological assessments and endpoint data quality, enhances the rater and patient experience, and integrates Medidata App innovations with Cogstate capabilities 29 October 2024 -- New York, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: October 29, 2024

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer

2 October 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 2, 2024

Owkin
https://www.owkin.com/
14/16 Bd Poissonnière, 75009 Paris

Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

New solution accelerates payments to patients participating in a clinical trial, improving experience and access 25 September 2024 -- New York, US -- Medidata, a Dassault Systèmes brand and leading...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 25, 2024

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...

Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

EORTC Extends Medidata Partnership to Help Power New Phased of Oncology Research

Medidata technology deployed to increase access to and transform the patient experience for cancer trials 11 September 2024 -- London, UK -- Medidata, a Dassault Systèmes brand and leading provider...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 11, 2024

Medidata
helpdesk@mdsol.com
350 Hudson Street New York, NY 10014 USA

AI can detect lung nodules that could lead to lung cancer nearly 3 years before symptoms and actual diagnosis, study finds

Evidence presented at 2024 World Conference on Lung Cancer highlights chest X-ray AI’s potential to detect lung nodules early and expedite patient care 10 September 2024 -- New York, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 10, 2024

Qure.AI
partner@qure.ai
C/O RODl & Partner Legal Limited, 170 Edmund Street, Birmingham, United Kingdom B3 2HB 74909